Abstract: The invention disclosed relates to the biological production of substantially isomerically pure (R)-baclofen and structurally related compounds, from the racemic mixture of (R)- and (S)-isomers thereof, and to the isolation of a Streptomyces microorganism from Nature which is capable of preferentially metabolizing one of the isomers while showing minimal metabolic activity on the other isomer. A fermentation or bioconversion process using this microorganism or the cell-free enzymes derived therefrom for the biological resolution of a racemic mixture of (R)- and (S)-baclofen and structurally related compounds is also disclosed.

Abstract: A binder system having a cover with interior and exterior front and back segments large enough to cover a plurality of pages with edges separated by a spine segment having a plurality of parallel scores defining substantially parallel spinal subsegments which bend and are secured to the edges of a plurality of papers with adhesive strips with removable covers to the spinal subsegments.

Abstract: The invention disclosed relates to a process for the preparation of sugar and sugar alcohol esters of general formula I(R--COO--).sub.n --R.sup.1 (I)wherein R is an alkyl group, R.sup.1 is derived from a sugar or a polyol moiety and n is 1 to 3, comprising reacting a sugar or a polyol with an acyl moiety, such as a carboxylic acid or ester, in a suitable solvent therefor and in the presence of an enzymatic catalyst capable of catalyzing the formation of ester bonds, and under reduced pressure sufficient to vaporize the solvent and by-product water, and continuously removing the water.

Abstract: The invention disclosed relates to a process for the enzymatic esterification and transesterification of racemic carboxylic acids and alcohols in which the reaction products predominantly include the ester of the more reactive acid or alcohol enantiomer and the less reactive acid or alcohol enantiomer, wherein the reactions are effected, preferably in a solventless medium, and the by-product water or short-chain alcohol is removed as it is formed.

Abstract: A dry porous macromolecular matrix is prepared comprising a cross-linked mixture of 69.9 to 86.6% by weight of an inert protein 0.4 to 10.2% by weight of a lipase enzyme and about 11.7 to 23% by weight of a cross-linking agent. The matrix is prepared by reacting the lipase, inert protein and cross-linking agent in a buffer solution, freezing the resulting reacted mixture at a temperature ranging between -20.degree. C. and -195.degree. C., allowing the frozen mixture to thaw to a temperature ranging from 4.degree. C. to 25.degree. C., and rinsing and drying the resulting product at room temperature.